Article Correctness Is Author's Responsibility: Examining therapeutic targets for kidney disease

(University of Houston) A University of Houston medical researcher is using a $1.4 million grant to target the suPAR protein found elevated in patients with kidney disease. In the past year, the same high serum suPAR levels have also been found to predict kidney and multiple organ failure in hospitalized patients with COVID-19.